MDNA Life Sciences, Inc.
🏢 View company profile →6Patents
6Active
6Granted
41Portfolio score
Filing activity: Aug 27, 2014 → Jun 3, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9745632B2 | Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers | Chemistry; Metallurgy | 11 | Active |
| US10308987B2 | 3.4 kb mitochondrial DNA deletion for use in the detection of cancer | Chemistry; Metallurgy | 4 | Active |
| US10400290B2 | Mitochondrial DNA deletion between about residues 12317-16254 for use in the detection of cancer | Chemistry; Metallurgy | 0 | Active |
| US10907213B2 | Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers | Chemistry; Metallurgy | 0 | Active |
| US10266899B2 | Aberrant mitochondrial DNA, associated fusion transcripts and hybridization probes therefor | Chemistry; Metallurgy | 0 | Active |
| US11111546B2 | 3.4 KB mitochondrial DNA deletion for use in the detection of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.